Literature DB >> 24452729

Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography.

Tomohisa Tada1, Adnan Kastrati, Robert A Byrne, Tibor Schuster, Rezarta Cuni, Lamin A King, Salvatore Cassese, Michael Joner, Jürgen Pache, Steffen Massberg, Albert Schömig, Julinda Mehilli.   

Abstract

We sought to compare the healing patterns of biolimus-eluting stents with biodegradable polymer (BP-BES, Nobori) versus everolimus-eluting stents with permanent polymer (PP-EES, Xience) using intravascular optical coherence tomography (OCT). A total of 34 patients undergoing treatment of de novo coronary lesions were randomly assigned to receive BP-BES (n = 15) or PP-EES (n = 19). Stent tissue coverage and apposition as well as the incidence of peri-strut low intensity area (PLIA) were assessed by OCT at 6-8 months. Generalized linear mixed models were used to account for clustered data. OCT imaging was available for 17 lesions with 2,805 struts in the BP-BES group and 22 lesions with 3,890 struts in the PP-EES group. BP-BES as compared to PP-EES showed similar rates of uncovered struts (479 vs. 588, odds ratio (OR) 1.54 (95 % CI 0.63-3.79), P = 0.34) and malapposed struts (46 vs. 32 struts, OR 1.64 [95 % CI 0.21-12.5], P = 0.64). Three lesions with BP-BES (17.6 %) versus 5 lesions with PP-EES (22.7 %) had >30 % uncovered struts (P = 0.78). The proportion of patients with PLIA was similar in both groups (BP-BES 41.2 % vs. PP-EES 36.4 %, OR 1.11 [95 % CI 0.43-2.87], P = 0.83). New generation BP-BES as compared to PP-EES showed similar stent coverage and apposition as assessed by OCT at 6-8 months. In addition, PLIA-possible markers of delayed arterial healing-were observed with similar frequency in both groups.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452729     DOI: 10.1007/s10554-014-0376-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

1.  Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.

Authors:  Stéphane Cook; Parham Eshtehardi; Bindu Kalesan; Lorenz Räber; Peter Wenaweser; Mario Togni; Aris Moschovitis; Rolf Vogel; Christian Seiler; Franz R Eberli; Thomas Lüscher; Bernhard Meier; Peter Jüni; Stephan Windecker
Journal:  Eur Heart J       Date:  2012-01-26       Impact factor: 29.983

2.  Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment.

Authors:  Tomohiko Teramoto; Fumiaki Ikeno; Hiromasa Otake; Jennifer K Lyons; Heleen M M van Beusekom; William F Fearon; Alan C Yeung
Journal:  Circ J       Date:  2010-04-29       Impact factor: 2.993

3.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

4.  Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.

Authors:  Giulio G Stefanini; Robert A Byrne; Patrick W Serruys; Antoinette de Waha; Bernhard Meier; Steffen Massberg; Peter Jüni; Albert Schömig; Stephan Windecker; Adnan Kastrati
Journal:  Eur Heart J       Date:  2012-03-24       Impact factor: 29.983

5.  Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials.

Authors:  Antoinette de Waha; Alban Dibra; Robert A Byrne; Gjin Ndrepepa; Julinda Mehilli; Massimiliano Fusaro; Karl-Ludwig Laugwitz; Steffen Massberg; Albert Schömig; Adnan Kastrati
Journal:  Circ Cardiovasc Interv       Date:  2011-07-26       Impact factor: 6.546

6.  Reproducibility of qualitative assessment of stent struts coverage by optical coherence tomography.

Authors:  Salvatore Brugaletta; Hector M Garcia-Garcia; Josep Gomez-Lara; Maria D Radu; Ravindra Pawar; Jamal Khachabi; Nico Bruining; Manel Sabaté; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-14       Impact factor: 2.357

7.  Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer.

Authors:  Juan Luis Gutiérrez-Chico; Peter Jüni; Héctor M García-García; Evelyn Regar; Eveline Nüesch; Francesco Borgia; Willem J van der Giessen; Simon Davies; Robert Jan van Geuns; Gioel Gabrio Secco; Susanne Meis; Stephan Windecker; Patrick W Serruys; Carlo di Mario
Journal:  Am Heart J       Date:  2011-10-07       Impact factor: 4.749

Review 8.  Polymer coatings and delayed arterial healing following drug-eluting stent implantation.

Authors:  R A Byrne; M Joner; A Kastrati
Journal:  Minerva Cardioangiol       Date:  2009-10       Impact factor: 1.347

9.  Endothelial cell recovery between comparator polymer-based drug-eluting stents.

Authors:  Michael Joner; Gaku Nakazawa; Aloke V Finn; Shawn Chin Quee; Leslie Coleman; Eduardo Acampado; Patricia S Wilson; Kristi Skorija; Qi Cheng; Xin Xu; Herman K Gold; Frank D Kolodgie; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2008-07-29       Impact factor: 24.094

10.  Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.

Authors:  Juan Luis Gutiérrez-Chico; Robert Jan van Geuns; Evelyn Regar; Willem J van der Giessen; Henning Kelbæk; Kari Saunamäki; Javier Escaned; Nieves Gonzalo; Carlo di Mario; Francesco Borgia; Eveline Nüesch; Héctor M García-García; Sigmund Silber; Stephan Windecker; Patrick W Serruys
Journal:  Eur Heart J       Date:  2011-06-09       Impact factor: 29.983

View more
  9 in total

1.  Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.

Authors:  Mahmoud Sabbah; Kazushige Kadota; Azza El-Eraky; Hanan M Kamal; Ahmed-Tageldien Abdellah; Ahmed El Hawary
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-25       Impact factor: 2.357

2.  Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.

Authors:  Ehsan Parsa; Sepideh Saroukhani; Fereshteh Majlessi; Hamidreza Poorhosseini; Masoumeh Lofti-Tokaldany; Arash Jalali; Mojtaba Salarifar; Ebrahim Nematipour; Mohammad Alidoosti; Hassan Aghajani; Alireza Amirzadegan; Seyed Ebrahim Kassaian
Journal:  Tex Heart Inst J       Date:  2016-04-01

3.  Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.

Authors:  Norihiro Kobayashi; Yoshiaki Ito; Masahiro Yamawaki; Motoharu Araki; Tsuyoshi Sakai; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutsumi; Masahiro Nauchi; Yohsuke Honda; Takahiro Tokuda; Kenji Makino; Shigemitsu Shirai; Keisuke Hirano
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-20       Impact factor: 2.357

4.  Vascular response to biolimus A-9 eluting stent in patients with shorter and prolonged dual antiplatelet therapy: optical coherence tomography sub-study of the NIPPON trial.

Authors:  Koji Kuroda; Toshiro Shinke; Hiromasa Otake; Hiroto Kinutani; Raisuke Iijima; Junya Ako; Hisayuki Okada; Yoshiaki Ito; Kenji Ando; Hitoshi Anzai; Hiroyuki Tanaka; Yasunori Ueda; Shin Takiuchi; Yasunori Nishida; Hiroshi Ohira; Katsuhiro Kawaguchi; Makoto Kadotani; Hiroyuki Niinuma; Kazuto Omiya; Takashi Morita; Kan Zen; Yoshinori Yasaka; Kenji Inoue; Sugao Ishiwata; Masahiko Ochiai; Toshimitsu Hamasaki; Kazushi Urasawa; Toru Kataoka; Minoru Yoshiyama; Kenshi Fujii; Takumi Inoue; Masahito Kawata; Hiroyoshi Yokoi; Masato Nakamura
Journal:  Heart Vessels       Date:  2018-02-20       Impact factor: 2.037

5.  Comparisons of early vascular reactions in biodegradable and durable polymer-based drug-eluting stents in the porcine coronary artery.

Authors:  Takeshi Ijichi; Gaku Nakazawa; Sho Torii; Hirofumi Nagamatsu; Ayako Yoshikawa; Junko Souba; Atsushi Isobe; Hitomi Hagiwara; Yuji Ikari
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

6.  Comparison of 9-Month Angiographic Follow-Up and Long-Term Clinical Outcomes of Biodegradable Polymer Drug-Eluting Stents and Second-Generation Durable Polymer Drug-Eluting Stents in Patients Undergoing Single Coronary Artery Stenting.

Authors:  Ming-Lung Tsai; Ming-Jer Hsieh; Chun-Chi Chen; Shang-Hung Chang; Chao-Yung Wang; Dong-Yi Chen; Chia-Hung Yang; Jih-Kai Yeh; Ming-Yun Ho; I-Chang Hsieh
Journal:  Acta Cardiol Sin       Date:  2020-03       Impact factor: 2.672

7.  Safety and efficacy of biodegradable drug-eluting vs. bare metal stents: a meta-analysis from randomized trials.

Authors:  Yangguang Yin; Yao Zhang; Xiaohui Zhao
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

8.  Clinical Characteristics and Prognosis of Peri-strut Low-intensity Area Detected by Optical Coherence Tomography.

Authors:  De-Wei Wu; Meng-Yue Yu; Hai-Yang Gao; Zhe He; Jing Yao; Cheng Ding; Bo Xu; Li Zhang; Fei Song; Qing-Rong Liu; Yong-Jian Wu
Journal:  Chin Med J (Engl)       Date:  2015-12-05       Impact factor: 2.628

9.  Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial.

Authors:  Himanshu Rai; Fernando Alfonso; Michael Maeng; Christian Bradaric; Jens Wiebe; Javier Cuesta; Evald Høj Christiansen; Salvatore Cassese; Petra Hoppmann; Roisin Colleran; Fiona Harzer; Jola Bresha; Nejva Nano; Simon Schneider; Karl-Ludwig Laugwitz; Michael Joner; Adnan Kastrati; Robert A Byrne
Journal:  Int J Cardiovasc Imaging       Date:  2021-08-21       Impact factor: 2.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.